1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cyclic gmp in 48 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (18.75) | 18.7374 |
1990's | 26 (54.17) | 18.2507 |
2000's | 13 (27.08) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosia, A; Bussolino, F; Garbarino, G; Ghigo, D; Heller, R; Pescarmona, G; Till, U | 1 |
Hisayama, T; Kondoh, W; Miyano, H; Moritoki, H; Takeuchi, S | 1 |
Ciapa, B; Randriamampita, C; Trautmann, A | 1 |
Drummer, C; Gerzer, R; Heim, JM; Karrenbrock, B; Valta-Seufzer, U | 1 |
Haslam, RJ; Maurice, DH | 1 |
Dickinson, KE; Hirschowitz, BI; Hokin, LE; Pruitt, RE; Sekar, MC | 1 |
Drummer, C; Gerzer, R; Heim, JM; Karrenbrock, B | 1 |
Auguet, M; Baranes, J; Braquet, P; Guillon, JM; Hellegouarch, A; Pirotzky, E | 1 |
Behrens, T; Goodwin, JS | 1 |
Hackenthal, E; Taugner, R | 1 |
Armstrong, RA; Jones, RL; Wilson, NH | 1 |
Loeb, AL; Peach, MJ; Singer, HA | 1 |
Bushfield, M; MacIntyre, DE; Shaw, AM | 1 |
Rink, TJ | 1 |
Alonso, F; Mato, JM; Sánchez-Crespo, M | 1 |
Alessio, P; Bussolino, F; Calvino, R; Fruttero, R; Gasco, A; Ghigo, D; Heller, R; Pescarmona, G; Till, U; Todde, R | 1 |
Alkon, DL; Inoue, H; Kouchi, T; Sakakibara, M; Yoshioka, T | 1 |
Bailly, C; Imbert-Teboul, M; Néant, F | 1 |
Anderson, DC; Granger, DN; Kubes, P; Kurose, I; Miyasaka, M; Paulson, J; Wolf, R | 1 |
Bosia, A; Bussolino, F; Calvino, R; Gasco, A; Ghigo, D; Heller, R; Pescarmona, GP; Till, U | 1 |
Alberola, ML; Caramelo, C; Casado, S; Esteban, A; López-Farré, A; Millás, I; Montón, M | 1 |
Emeis, JJ; Tranquille, N | 1 |
Karlsson, JA; Raeburn, D | 1 |
Bozzaro, S; Bussolino, F; Cristino, E; Sordano, C; Wurster, B | 1 |
Befus, AD; Hogaboam, CM; Wallace, JL | 1 |
Howard, KM; Mustafa, SB; Olson, MS | 1 |
Kamata, K; Kasuya, Y; Numazawa, T | 1 |
Hirafuji, M; Minami, M; Nezu, A; Shinoda, H | 1 |
Bergamaschi, M; Bongrani, S; Caruso, P; Civelli, M; Gasco, A; Giossi, M; Razzetti, R | 1 |
Calcerrada, MC; Catalán, RE; Hernández, F; Martínez, AM; Pérez, MJ | 1 |
Barkin, M; Barnett, CC; Moore, EE; Offner, PJ; Partrick, DA; Silliman, CC | 1 |
Alves, AC; Cordeiro, RS; e Silva, PM; Lagente, V; Martins, MA; Pires, AL | 1 |
Calcerrada, MC; Catalán, RE; Martínez, AM | 1 |
Boronkay, E; Gyürky, J; Herbert, JM; Kapui, Z; Mikus, EG; Pascal, M; Schaeffer, P | 1 |
Fox-Robichaud, A; Kubes, P; Payne, D | 1 |
Fukuda, S; Predescu, DN; Schmid-Schönbein, GW; Yasu, T | 1 |
Chen, JS; Chen, LW; Shen, AY; Wu, SN | 1 |
Ko, FN; Liao, CH; Teng, CM; Wu, CL | 1 |
Kelly, RF | 1 |
Murota, M; Sakai, H; Suzuki, T; Takahashi, Y; Takeguchi, N | 1 |
Bazan, NG; Bernatchez, PN; Gélinas, DS; Rollin, S; Sirois, MG | 1 |
Bussolati, B; Camussi, G; Mariano, F; Migliori, M; Russo, S; Triolo, G | 1 |
Bredt, DS; Hua, Z; Johns, RA; Tao, YX; Xu, Y; Zhang, B | 1 |
Ameer, A; Ibe, BO; Portugal, AM; Raj, JU; Renteria, L | 1 |
Andersson, J; Bengtsson, T; Grenegård, M; Kälvegren, H | 1 |
Eckert, RE; Jones, SL | 1 |
Dohi, T; Kitayama, T; Morioka, N; Morita, K | 1 |
Chin, TK; Hofmann, PA; Leary, PJ; Morrison, RR; Rajasekaran, S; Tuomanen, EI | 1 |
3 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cyclic gmp
Article | Year |
---|---|
Hormonal signals and intracellular messengers for renin secretion.
Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Histamine; Hormones; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Platelet Activating Factor; Prostaglandins; Renin; Vasopressins | 1986 |
Stimulus-response coupling mechanisms in human platelets.
Topics: Blood Platelets; Calcium; Cell Membrane Permeability; Contractile Proteins; Cyclic AMP; Cyclic GMP; Diglycerides; Humans; Hydrogen-Ion Concentration; Inositol Phosphates; Physical Stimulation; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins; Stimulation, Chemical; Thromboxanes; Transduction, Genetic | 1986 |
Current strategies in lung preservation.
Topics: Animals; Antioxidants; Cold Temperature; Cyclic AMP; Cyclic GMP; Free Radical Scavengers; History, 20th Century; Humans; Lung; Lung Injury; Lung Transplantation; Organ Preservation; Platelet Activating Factor; Reperfusion Injury; Respiration, Artificial; Solutions; Vasodilator Agents | 2000 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cyclic gmp
Article | Year |
---|---|
Comparison of anti-platelet properties of molsidomine, isosorbide-5-mononitrate and placebo in healthy volunteers.
Topics: Adult; Bleeding Time; Cyclic GMP; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isosorbide Dinitrate; Male; Molsidomine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Random Allocation; Reference Values; Thromboxane B2 | 1991 |
44 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cyclic gmp
Article | Year |
---|---|
Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells.
Topics: Acetyltransferases; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Humans; Molsidomine; Nitroprusside; Platelet Activating Factor; Thrombin | 1992 |
Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
Topics: Aging; Animals; Aorta, Thoracic; Arginine; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Hemoglobins; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar | 1992 |
Cyclic-GMP-dependent refilling of calcium stores in macrophages.
Topics: Adenosine Triphosphate; Aminoquinolines; Animals; Biological Transport; Biological Transport, Active; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Cyclic GMP; Cytophotometry; Macrophages; Mice; Platelet Activating Factor; SRS-A | 1991 |
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Topics: Adenosine; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Enzyme Activation; Ferricyanides; Hemoglobins; In Vitro Techniques; Kinetics; Molsidomine; Nitroprusside; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinolones; Rabbits; Radioimmunoassay; Vasodilator Agents | 1990 |
Muscarinic receptor antagonist activity of diacylglycerol lipase and kinase inhibitors.
Topics: Animals; Brain; Cells, Cultured; Cyclic GMP; Cyclohexanes; Cyclohexanones; Guinea Pigs; Heart; Lipoprotein Lipase; Myocardium; N-Methylscopolamine; Pancreas; Parasympatholytics; Platelet Activating Factor; Pyrimidinones; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Thiazoles; Tritium | 1990 |
Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Topics: Cyclic GMP; Enzyme Activation; In Vitro Techniques; Molsidomine; Nitrates; Nitric Oxide; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents | 1989 |
Lack of effect of atrial natriuretic factor on the tone induced in rat portal vein by platelet-activating factor.
Topics: Animals; Atrial Natriuretic Factor; Bucladesine; Cyclic GMP; In Vitro Techniques; Male; Muscle Tonus; Nitroprusside; Platelet Activating Factor; Portal Vein; Rats | 1988 |
Role of lipoxygenase metabolites of arachidonic acid in T cell activation.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cyclic GMP; Humans; Leukotriene B4; Leukotrienes; Lipid Peroxides; Lipoxygenase; Lymphocyte Activation; Mice; Platelet Activating Factor; T-Lymphocytes | 1988 |
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
Topics: Adenosine Diphosphate; Aspirin; Cyclic AMP; Cyclic GMP; Dinoprost; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins F; Prostaglandins H; Prostaglandins, Synthetic; Thrombin | 1985 |
Mechanisms of endothelium-dependent vascular smooth muscle relaxation.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Calcium; Cyclic GMP; Cyclooxygenase Inhibitors; Endothelium; Humans; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Platelet Activating Factor; Receptors, Muscarinic; Vasoconstriction; Vasodilation; Vasodilator Agents | 1985 |
Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C.
Topics: Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Cytosol; Diglycerides; Fluorescent Dyes; Humans; In Vitro Techniques; Platelet Activating Factor; Protein Kinase C; Protein Kinases; Spectrometry, Fluorescence | 1985 |
Modulatory role of cyclic AMP in the release of platelet-activating factor from human polymorphonuclear leucocytes.
Topics: Blood Coagulation Factors; Blood Platelets; Cyclic AMP; Cyclic GMP; Epinephrine; Glucuronidase; Humans; Isoproterenol; Lysophosphatidylcholines; Phosphodiesterase Inhibitors; Pilocarpine; Platelet Activating Factor; Platelet Aggregation; Zymosan | 1982 |
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; Acetyltransferases; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Humans; Iloprost; Oxadiazoles; Platelet Activating Factor; Platelet Aggregation Inhibitors; Thrombin; Umbilical Veins | 1993 |
Induction of photoresponse by the hydrolysis of polyphosphoinositides in the Hermissenda type B photoreceptor.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cyclic AMP; Cyclic GMP; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Hydrolysis; Inositol 1,4,5-Trisphosphate; Kinetics; Lithium Chloride; Models, Biological; Neomycin; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Photoreceptor Cells, Invertebrate; Platelet Activating Factor; Pyrimidinones; Snails; Spermine; Thiazoles; Thionucleotides; Type C Phospholipases | 1994 |
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Calcium; Chlorides; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoquinolines; Kidney Medulla; Kinetics; Loop of Henle; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Parathyroid Hormone; Platelet Activating Factor; Protein Kinase C; Time Factors; Vasopressins | 1994 |
Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage.
Topics: Albumins; Animals; Arginine; Azepines; Blood Flow Velocity; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cyclic GMP; Intercellular Adhesion Molecule-1; Leukocytes; Male; NG-Nitroarginine Methyl Ester; P-Selectin; Phalloidine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Triazoles; Venules | 1993 |
Activation of endothelial guanylate cyclase inhibits cellular reactivity.
Topics: Arachidonic Acid; Cell Adhesion; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Guanylate Cyclase; Humans; Molsidomine; Nitric Oxide; Nitroprusside; Oxadiazoles; Platelet Activating Factor; Thrombin; Umbilical Veins | 1995 |
Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1.
Topics: Animals; Aspirin; Blood Platelets; Calcium; Citrulline; Cyclic GMP; Endothelins; Humans; In Vitro Techniques; Neutrophils; Nitric Oxide; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Rabbits | 1995 |
The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Atrial Natriuretic Factor; Bradykinin; Colforsin; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Male; Nitroprusside; Platelet Activating Factor; Rats; Rats, Wistar; Secretory Rate; Tissue Plasminogen Activator; von Willebrand Factor | 1993 |
Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; Albuterol; Animals; Bronchi; Capillary Permeability; Cyclic AMP; Cyclic GMP; Guinea Pigs; Isoenzymes; Male; Nitroprusside; Phosphodiesterase Inhibitors; Platelet Activating Factor; Trachea | 1993 |
Platelet activating factor modulates signal transduction in Dictyostelium.
Topics: Animals; Calcium; Cyclic AMP; Cyclic GMP; Dictyostelium; Nephelometry and Turbidimetry; Platelet Activating Factor; Signal Transduction; Stereoisomerism | 1993 |
Modulation of rat mast cell reactivity by IL-1 beta. Divergent effects on nitric oxide and platelet-activating factor release.
Topics: Animals; Cyclic GMP; Interleukin-1; Male; Mast Cells; Nitric Oxide; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombin | 1993 |
Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
Topics: Animals; Arginine; Biological Transport, Active; Cells, Cultured; Cyclic GMP; Cycloheximide; Dactinomycin; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Kinetics; Kupffer Cells; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Shock, Septic | 1996 |
Mechanisms of desensitization of vasodilatation induced by platelet-activating factor in hypertensive rats.
Topics: Acetylcholine; Animals; Cyclic GMP; GTP-Binding Proteins; Hypertension; Hypertension, Renovascular; In Vitro Techniques; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Pertussis Toxin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Vasodilation; Virulence Factors, Bordetella | 1996 |
Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Topics: Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Endothelium, Vascular; Humans; In Vitro Techniques; Indomethacin; Leukocytes; Methylene Blue; Neutrophils; Nitric Oxide; Nitroprusside; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Adhesiveness; Purinones; Rabbits | 1996 |
The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Aorta; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Oxadiazoles; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1996 |
Nitric oxide mediates the PAF-stimulated cyclic GMP production in hippocampal slices.
Topics: Animals; Arginine; Cyclic GMP; Dihydropyridines; Enzyme Inhibitors; Hippocampus; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Platelet Activating Factor; Rats; Rats, Wistar | 1996 |
Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway.
Topics: Adult; Analysis of Variance; Cyclic GMP; Dibutyryl Cyclic GMP; Humans; In Vitro Techniques; Kinetics; Leukocyte Elastase; Models, Biological; Molsidomine; Neutrophils; Nitric Oxide; Platelet Activating Factor; Signal Transduction; Substrate Specificity | 1997 |
Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro.
Topics: Analysis of Variance; Animals; Cell Movement; Chemotactic Factors, Eosinophil; Cyclic AMP; Cyclic GMP; Eosinophils; Leukotriene B4; Phosphodiesterase Inhibitors; Platelet Activating Factor; Rats; Rats, Wistar | 1997 |
Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus.
Topics: Animals; Cyclic GMP; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Male; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Riluzole | 1999 |
Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bronchoconstriction; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Epithelial Cells; Guinea Pigs; Histamine; In Vitro Techniques; Isoenzymes; Male; Muscle Tonus; Phosphodiesterase Inhibitors; Platelet Activating Factor; Respiratory System; Trachea | 1999 |
Inhaled NO reaches distal vasculatures to inhibit endothelium- but not leukocyte-dependent cell adhesion.
Topics: Administration, Inhalation; Animals; Capillary Permeability; Cats; Cell Adhesion; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Hydrogen Peroxide; Leukocytes; Leukotriene B4; Lung; Microscopy, Video; Nitric Oxide; Oxadiazoles; Oxidants; Oxidative Stress; P-Selectin; Platelet Activating Factor; Quinoxalines | 1999 |
Mechanisms for regulation of fluid shear stress response in circulating leukocytes.
Topics: Aminoquinolines; Animals; Cell Adhesion; Cyclic GMP; Humans; In Vitro Techniques; Leukocytes; Methylene Blue; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Formylmethionine Leucyl-Phenylalanine; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet Activating Factor; Rats; Rats, Wistar; Stress, Physiological | 2000 |
Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel.
Topics: Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cyclic GMP; Egtazic Acid; Enzyme Activation; Humans; Imidazoles; Loperamide; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Protein Kinase C; Tetradecanoylphorbol Acetate | 2000 |
Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Animals; Arachidonic Acid; Bibenzyls; Blood Platelets; Calcium; Collagen; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Ethers, Cyclic; Phosphatidylinositols; Plants, Medicinal; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thrombin; Thromboxane B2 | 2000 |
Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2.
Topics: Animals; Camptothecin; Chlorides; Colon; Cyclic GMP; Enzyme Inhibitors; Female; Gene Expression; Imidazoles; Intestinal Mucosa; Irinotecan; Membrane Potentials; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Parasympathomimetics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; RNA, Messenger; Thromboxane A2 | 2002 |
Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Topics: 1-Methyl-3-isobutylxanthine; Androstadienes; Animals; Calcimycin; Calcium; Cattle; Cells, Cultured; Chelating Agents; Chromones; Cyclic GMP; Diterpenes; Dose-Response Relationship, Drug; Egtazic Acid; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Ginkgolides; Indoles; Intercellular Signaling Peptides and Proteins; Ionophores; Lactones; Lymphokines; Maleimides; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serine; Signal Transduction; Time Factors; Type C Phospholipases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wortmannin | 2002 |
Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production.
Topics: Adult; Arginine; Cells, Cultured; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Humans; Lipopolysaccharides; Monocytes; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Platelet Activating Factor; Stereoisomerism; Tumor Necrosis Factor-alpha | 2003 |
Targeted disruption of PSD-93 gene reduces platelet-activating factor-induced neurotoxicity in cultured cortical neurons.
Topics: Animals; Blotting, Western; Cell Count; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Diterpenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluorescent Antibody Technique; Ginkgolides; Guanylate Kinases; Intracellular Signaling Peptides and Proteins; Lactones; Membrane Proteins; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Tissue Proteins; Neurons; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Platelet Activating Factor; Precipitin Tests; Propidium; Receptors, N-Methyl-D-Aspartate | 2004 |
Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Female; Fetus; Inositol 1,4,5-Trisphosphate; Lung; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pregnancy; Receptors, G-Protein-Coupled; Sheep | 2007 |
Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.
Topics: Adenosine Triphosphate; Adult; Aspirin; Caffeic Acids; Cell Line, Tumor; Chlamydophila pneumoniae; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Flavanones; Humans; Lipoxygenase Inhibitors; Piroxicam; Platelet Activating Factor; Platelet Aggregation; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12 | 2007 |
Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
Topics: Actins; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Chemotaxis; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Humans; Interleukin-8; Leukotriene B4; Microfilament Proteins; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphoproteins; Phosphorylation; Platelet Activating Factor; Protein Kinase C; Serine; Signal Transduction; Tumor Necrosis Factor-alpha | 2007 |
Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate-NO-cyclic GMP signalling in spinal cord in mice.
Topics: Animals; Cyclic GMP; Glutamic Acid; Male; Mice; Nitric Oxide; Pain; Pain Measurement; Platelet Activating Factor; Receptors, Glycine; Signal Transduction; Spinal Cord; Touch | 2008 |
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.
Topics: Animals; Calcium; Calcium Signaling; Cell Shape; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Female; Ginkgolides; Lactones; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Platelet Activating Factor; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left | 2008 |